Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
"nIntroduction: To evaluate the efficacy and safety of Carboplatin plus Paclitaxel in patients with advanced locoregional recurrence and metastatic endometrial cancer. "nPatient and Method: 32 eligible patients (median age 62, range 41-72) with measurable endometrial cancer were tr...
Main Authors: | Hamid Attarian, H Rezvani, M GHadyani, S Attarian, Okhovatian, A Khosravi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2009-07-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16095.pdf&manuscript_id=16095 |
Similar Items
-
Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
by: Hamid Attarian, et al.
Published: (2009-09-01) -
The Clinical Analysis of Paclitaxel at Two Dose Levels plus Carboplatin as the First-line Treatment in Advanced Non-small Cell Lung Cancer
by: Jialin QIAN, et al.
Published: (2011-04-01) -
Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel: Two Case Reports
by: Tomoyuki Araya, et al.
Published: (2020-12-01) -
Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
by: Yuri Ueda, et al.
Published: (2020-10-01) -
Ischemic Colitis Associated with Paclitaxel and Carboplatin Combination
by: Ahmed Gamal Elsayed, et al.
Published: (2017-08-01)